98292345 - NEORANKER

Information

• Trademark
• 98292345

• Source

• Serial Number

  98292345

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  November 30, 2023
  9 months ago

• Transaction Date

  July 05, 2024
  2 months ago

• Status Date

  July 05, 2024
  2 months ago

• Location Date

  February 23, 2024
  6 months ago

• Status Code

  641

• Employee Name

  LEASER, ANDREW C

• Attorney Name

  Rebecca Liebowitz

• Owners

  • ACHILLES THERAPEUTICS UK LIMITED

Case File Statements

• GS0401: Custom manufacture of therapeutic drugs; namely custom manufacture of cell therapies and cancer therapies
• GS0091: Bioinformatics software; computer software platforms
• GS0051: Medical and veterinary preparations for therapeutic purposes; preparations for cancer therapy; antibodies; vaccines; preparations for cell therapy; preparations for modifying human or animal cells for medical or therapeutic purposes; preparations of blood extracted from humans or animals which have been adapted for medical or therapeutic purposes
• PM0001: NEO RANKER
• GS0441: Medical services; veterinary services; services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies
• GS0421: Scientific and technological services and research and design relating thereto; industrial analysis and research services; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research into cancer evolution and clonal architecture; scientific research in human and animal cell therapy; scientific research into vaccines; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; Software as a service; providing a bioinformatics platform for manufacturing therapeutics; providing a bioinformatics platform for identifying neoantigens

Case File Event Statements

• 11/30/2023 - 9 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 2/23/2024 - 6 months ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/28/2024 - 2 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 7/5/2024 - 2 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/5/2024 - 2 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/5/2024 - 2 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN